Big data and the health sector: the way forward
Welcome and introduction by the Chair, Birgitta Sacrédeus
The Chair, Birgitta Sacrédeus welcomed the participants and introduced the topic of the meeting: “Big data and the health sector: the way forward”. Ms Sacrédeus highlighted that the healthcare industry generates large amounts of data and it is now time to learn how to make
Ms Sacrédeus then gave the floor to Mr Arnaud Senn, Policy Officer, Unit E-Health, Well-Being and Ageing, DG CNECT, European Commission.
Management of Big Data: the Future of Health in Europe
Arnaud Senn, Policy Officer, Unit E-Health, Well-Being and Ageing, DG CNECT, European Commission
Mr Senn started by stating that the digitisation of economies and
The European Commission has recently conducted a Mid-Term Review of the Digital Single Market which also included an EU-wide survey aimed at taking into account citizens’ expectations and feelings about health data. The results showed that few citizens have easy access to their own data. In addition, very few hospitals allow citizens to access their own medical records (only 10% actually do grant easy access). As a consequence,
To this end, the Communication on Enabling the Digital Transformation of Health and Care in the Digital Single Market identifies three main priorities around which activities must be developed at local, regional, national, and European level:
- Securing data access and sharing, especially in cross-border cooperation
- Pooling health data for research, faster diagnosis and improved health
- Digital tools and data for citizen empowerment and
person-centered health care
Mr Senn also underlined that, in order to advance in digital health, it is important to build on the already-existing regional experiences and mentioned the European Innovation Partnership (EIP) initiative as a very valuable tool. The EIP focuses on different action groups, each of them focusing on topics of common interest. The initiative has been successfully mobilizing people from the academic community, the civil society, the industry, and regional authorities and got them to work together on different issues with the support of technology. It has mainly focused on how to make
In addition to the EIP, the European Commission has supported a wide range of innovative projects in the field of digital health. One of
- How to define patient engagement
- How to measure patient engagement
- How to promote patient engagement
- What role e-health technologies can play
Mr Senn concluded by saying that citizens have
The Chair gave then the floor to regional experiences in the field.
Regional Best Practices: Health Data Analytics for Research and Innovation of Catalonia
Toni Dedeu, Director, Agency for Health Quality and Assessment of Catalonia Ministry of Health, Government of Catalonia
Mr Dedeu presented the Programme for Health Data Analytics of Catalonia (
When the process started, in 2013, there was a very serious political reaction: people were frightened about the use of very sensitive data, as they did not know the concept of big data at all. They did not want to develop a programme which could share their own sensitive information. They were concerned about the possible use of the data. So, the agency started a public debate which lasted for more than three years and brought all the parties together (politicians, researches, the public in general, the industry, medical societies, patients groups, etc.) in order to address this communication problem and eventually reached a consensus. Mr Dedeu highlighted that one of the key commitments included in the consensus agreement was transparency on what happens with the information provided and how it is used.
Before the programme, researchers needed to collect the data by consulting different sources. Now the idea is to have one single agency which is able to access all the existing data sets. Today researchers, planners, and innovators can go to the agency, present a study research proposal and ask to be granted access to the data they need.
The legal framework of the programme has always been the General Data Protection Regulation (GDPR), as the regulation was already written when the programme was designed. In addition to the GDPR, if someone has any doubt about the use of health data, they can consult the Data Protection Authority in Catalonia. Mr Dedeu also explained that the programme has an opt-out approach, which means that, unless you state that you don’t want to share the information for research purposes, your data will automatically become available. So far only 30 people out of 7.5 million citizens have opted out. Moreover, every study proposal must go through the assessment of an Ethical Committee before being able to access the programme.
Mr Dedeu also underlined that the programme is based on key ethical principles, such as:
- respect for people;
- patient-to-patient solidarity (everyone understands that their own data is a common good for the society as a whole);
- justice (when granting access to anonymised data for research purposes, priority is given to minorities such as research studies on rare diseases);
- efficiency (the programme does not affect the normal budget allocated for healthcare provision)
The programme also has a well-defined governance structure consisting of the Operational Committee of the agency (chaired by Mr Dedeu), an external Monitoring Committee which is accountable to the society for what the programme does, an Advisory Board, an Executive Board.
Mr Dedeu concluded by saying that the programme has demonstrated that, through the use of big data, there is an improvement of the research capacity and care processes which leads to a significant improvement of the health of the population.
Big Data in a World of Non-Communicable Chronic Diseases
Prof Josep Redón, Head of the Internal Medicine Institute, University Clinic Hospital of Valencia
Mr Redón’s presentation focused on the use of big data in non-communicable chronic diseases (NCCDs). Chronic diseases are those diseases requiring continuous management over a period of years and decades and are related to the concepts of multi-morbidity and co-morbidity. The former refers to the concurrent presence of two or more non-communicable chronic diseases with no apparent links between each other. The latter implies that there are well-established links between the different NCCDs. Mr Redón highlighted that age is an important factor in order to establish multimorbidity, as the oldest the people are, the highest the percentage of multimorbidity is. Moreover, NCCDs account for 80% of the total healthcare budget of the EU. Therefore, we are already investing a lot in NCCDs and we risk losing a lot of resources in the future. This is the main threat facing the management of healthcare in the future and the use of big data can help address the issue.
Mr Redón then talked about the potential for big data in the health sector. Big data can help in healthcare management, risk assessment, clinical issues and therapeutics. Moreover, they can be particularly useful for a better understanding, planning and delivering of prevention and care in NCCDs, as they can support many activities, such as surveillance, the creation of a prevention-driven approach, proactive prevention, research and comparative studies (such as the
Mr Redón also gave some practical examples of how big data can be used in the health sector to see what is happening in a given population. Big data allow doing multi-layer levels of research by crossing data from clinical data, –
However, the management of big data also faces a number of obstacles, such as:
- Clinical and cultural obstacles:
- Legal framework:
the General Data Protection Regulation (GDPR) has enhanced the individual rights of patients and has underlined the importance of the accountability of the organisation using the data;
- Technical challenges:
The current electronic health records store relevant information but have limited capabilities to perform data analytics or prediction. Moreover, the issue of unstructured data is very important.
Finally, Mr Redón talked about the Bigmedilytics project, an EU-funded project aiming to transform the EU healthcare sector by using state-of-the-art Big Data technologies to achieve breakthrough productivity by:
- reducing costs
- improving patient outcomes
- delivering better access to healthcare facilities
Mr Redón concluded by outlining four main
NCCDsaccount for 80% of the health carecost in Europe and the percentage is rapidly increasing;
- Big-data (real-world data) is a valuable tool for improving health care quality, for better planning, and to reduce costs;
- Despite some challenges, a rapid development of the use of big data can bring about important changes;
- The European Parliament should provide a new framework to facilitate cooperation across the EU so as to speed up advances in the health sector.
Close of meeting
The Chair thanked the Committee of the Regions for hosting the meeting and the speakers, as well as the participants.
The next meeting of the CoR Interregional Group on Health and Well-being will take place on 9 October on the topic “Global Challenges, Territorial Answers: the Future of Health in Europe”. The meeting will be part of the European Week of Regions and Cities 2018 and will involve high-level speakers and participants. Further information about the event will be circulated soon.